Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Risk factors for severe cranial ischaemic complications in giant cell arteritis.

Hočevar A, Ješe R, Tomšič M, Rotar Ž.

Rheumatology (Oxford). 2020 Mar 3. pii: keaa058. doi: 10.1093/rheumatology/keaa058. [Epub ahead of print]

PMID:
32125431
2.
3.

Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study.

Rotar Z, Svetina P, Tomsic M, Hočevar A, Prapotnik S.

BMJ Open. 2020 Feb 5;10(2):e034356. doi: 10.1136/bmjopen-2019-034356.

4.

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.

Michelsen B, Ørnbjerg LM, Kvien TK, Pavelka K, Nissen MJ, Nordström D, Santos MJ, Koca SS, Askling J, Rotar Z, Gudbjornsson B, Codreanu C, Loft AG, Kristianslund EK, Mann HF, Ciurea A, Eklund KK, Vieira-Sousa E, Yazici A, Jacobsson L, Tomšič M, Löve TJ, Ionescu R, van der Horst-Bruinsma IE, Iannone F, Pombo-Suarez M, Jones GT, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M.

Rheumatology (Oxford). 2020 Jan 20. pii: kez656. doi: 10.1093/rheumatology/kez656. [Epub ahead of print]

PMID:
31960053
5.

Multifocal Thrombophlebitis and Orbital Cellulitis.

Hočevar A, Šuput Skvarča D, Tomšič M, Perdan Pirkmajer K.

Am J Case Rep. 2020 Jan 14;21:e919715. doi: 10.12659/AJCR.919715.

6.

Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.

Bertoli F, Šuštar M, Jarc Vidmar M, Perovšek D, Brecelj J, Markelj Š, Jaki Mekjavić P, Šuput D, Tomšič M, Isola M, Battistella C, Lanzetta P, Hawlina M.

Doc Ophthalmol. 2020 Jan 11. doi: 10.1007/s10633-019-09744-0. [Epub ahead of print]

PMID:
31927702
7.

Predicting gastrointestinal and renal involvement in adult IgA vasculitis.

Hočevar A, Tomšič M, Jurčić V, Perdan Pirkmajer K, Rotar Ž.

Arthritis Res Ther. 2019 Dec 26;21(1):302. doi: 10.1186/s13075-019-2089-2.

8.

Structural, rheological and dynamic aspects of hydrogen-bonding molecular liquids: Aqueous solutions of hydrotropic tert-butyl alcohol.

Cerar J, Jamnik A, Pethes I, Temleitner L, Pusztai L, Tomšič M.

J Colloid Interface Sci. 2020 Feb 15;560:730-742. doi: 10.1016/j.jcis.2019.10.094. Epub 2019 Oct 25.

PMID:
31704003
9.

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.

Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.

Rheumatology (Oxford). 2019 Oct 30. pii: kez427. doi: 10.1093/rheumatology/kez427. [Epub ahead of print]

PMID:
31665497
10.

Supramolecular structure vs. rheological properties: 1,4-Butanediol at room and elevated temperatures.

Tomšič M, Cerar J, Jamnik A.

J Colloid Interface Sci. 2019 Dec 1;557:328-335. doi: 10.1016/j.jcis.2019.09.020. Epub 2019 Sep 6.

PMID:
31525670
11.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427. Epub 2019 Aug 20.

PMID:
31431486
12.

Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.

Putrik P, Ramiro S, Guillemin F, Péntek M, Sivera F, Sokka T, de Wit M, Woolf AD, Zink A, Andersone D, Berghea F, Butrimiene I, Brouwer S, Cassar K, Charalambous P, Caporali R, Deseatnicova E, Damjanov NS, Finckh A, FitzGerald O, Gröndal G, Gobejishjvili N, Gluszko P, Hirsch M, Jovanovic I, Vencovský J, Janssens X, Keszei AP, Kovarova M, Kull M, Cunha Miranda L, Mayer M, Misevska-Percinkova S, Inanc N, Nadashkevich O, Petersson IF, Puolakka K, Rojkovich B, Radner H, Szabados F, Slobodin G, Shirinsky I, Soroka N, Sidiropoulos P, Shumnalieva R, Sokolovic S, Shukurova S, Tafaj A, Tomšič M, Uhlig T, Verstappen SMM, Boonen A.

Ann Rheum Dis. 2019 Nov;78(11):1472-1479. doi: 10.1136/annrheumdis-2019-215294. Epub 2019 Aug 19.

PMID:
31427438
13.

The incidence of spondyloarthritis in Slovenia.

Hočevar A, Potočnik Pucelj N, Ješe R, Pavič-Nikolič M, Tomšič M, Rotar Z.

Medicine (Baltimore). 2019 Jun;98(26):e16177. doi: 10.1097/MD.0000000000016177.

14.

Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis - the SHARE initiative.

Hočevar A, Ostrovršnik J, Tomšič M, Rotar Ž.

Rheumatology (Oxford). 2019 Sep 1;58(9):1695-1697. doi: 10.1093/rheumatology/kez241. No abstract available.

PMID:
31170291
15.

ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.

Kobold N, Jenko B, Tomšič M, Dolžan V, Praprotnik S.

Isr Med Assoc J. 2019 May;5(21):333-338.

16.

Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?

Praprotnik S, Hočevar A, Rotar Ž, Tomšič M, Gašperšič N, Perdan Pirkmajer K.

Rheumatology (Oxford). 2019 Jul 1;58(7):1310-1312. doi: 10.1093/rheumatology/kez082. No abstract available.

PMID:
30859223
17.

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.

Lakota K, Perdan-Pirkmajer K, Sodin-Šemrl S, Čučnik S, Šubelj V, Prosenc K, Mrak Poljšak K, Tomšič M, Ambrožič A, Praprotnik S.

Clin Rheumatol. 2019 May;38(5):1277-1292. doi: 10.1007/s10067-019-04439-y. Epub 2019 Feb 14.

PMID:
30761436
18.

IgA vasculitis in adults: few certainties and many uncertainties.

Hočevar A, Tomšič M, Rotar Ž.

Ann Rheum Dis. 2020 Apr;79(4):e47. doi: 10.1136/annrheumdis-2018-214907. Epub 2019 Jan 5. No abstract available.

PMID:
30612119
20.

Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration.

Chatzidionysiou K, Lukina G, Gabay C, Hetland ML, Hauge EM, Pavelka K, Nordström D, Canhão H, Tomsic M, Rotar Z, Lie E, Kvien TK, van Vollenhoven RF, Saevarsdottir S.

Scand J Rheumatol. 2019 Jan;48(1):17-23. doi: 10.1080/03009742.2018.1466363. Epub 2018 Sep 27.

PMID:
30260261
21.

Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories.

Lakota K, Švec T, Kveder T, Sodin-Šemrl S, Žigon P, Ambrožič A, Ogrič M, Markez S, Božič B, Tomšič M, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):353-359. doi: 10.1007/s10067-018-4271-3. Epub 2018 Sep 10.

PMID:
30203316
22.

Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients.

Burja B, Feichtinger J, Lakota K, Thallinger GG, Sodin-Semrl S, Kuret T, Rotar Ž, Ješe R, Žigon P, Čučnik S, Mali P, Praprotnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):317-329. doi: 10.1007/s10067-018-4240-x. Epub 2018 Aug 24.

PMID:
30143961
23.

Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.

Žigon P, Podovšovnik A, Ambrožič A, Tomšič M, Hočevar A, Gašperšič N, Rotar Ž, Praprotnik S, Šemrl SS, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):371-378. doi: 10.1007/s10067-018-4251-7. Epub 2018 Aug 11.

PMID:
30099654
24.

Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event.

Gašperšič N, Zaletel M, Kobal J, Žigon P, Čučnik S, Šemrl SS, Tomšič M, Ambrožič A.

Clin Rheumatol. 2019 Feb;38(2):379-384. doi: 10.1007/s10067-018-4247-3. Epub 2018 Aug 7.

PMID:
30088114
25.

Does leflunomide have a role in giant cell arteritis? An open-label study.

Hočevar A, Ješe R, Rotar Ž, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):291-296. doi: 10.1007/s10067-018-4232-x. Epub 2018 Aug 6.

PMID:
30084049
26.

MicroRNA expression in the affected skin of adult patients with IgA vasculitis.

Hočevar A, Tomšič M, Pižem J, Bolha L, Sodin-Šemrl S, Glavač D.

Clin Rheumatol. 2019 Feb;38(2):339-345. doi: 10.1007/s10067-018-4250-8. Epub 2018 Aug 6.

PMID:
30084048
27.

Antiphospholipid antibodies in adult IgA vasculitis: observational study.

Hočevar A, Rotar Ž, Žigon P, Čučnik S, Ostrovršnik J, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):347-351. doi: 10.1007/s10067-018-4248-2. Epub 2018 Aug 2.

PMID:
30073461
28.

The incidence of idiopathic inflammatory myopathies in the adult Slovenian population.

Ostrovršnik J, Hočevar A, Rotar Ž, Krošel M, Čučnik S, Jurčić V, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):279-283. doi: 10.1007/s10067-018-4237-5. Epub 2018 Aug 2.

PMID:
30073460
29.

The incidence rate and the early management of rheumatoid arthritis in Slovenia.

Ješe R, Perdan-Pirkmajer K, Hočevar A, Rotar Ž, Markez S, Pavič-Nikolič M, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):273-278. doi: 10.1007/s10067-018-4235-7. Epub 2018 Aug 2.

PMID:
30073459
30.

Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis.

Kuret T, Lakota K, Žigon P, Ogrič M, Sodin-Šemrl S, Čučnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):331-338. doi: 10.1007/s10067-018-4234-8. Epub 2018 Aug 2.

PMID:
30073458
31.

Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies.

Kuret T, Burja B, Feichtinger J, Thallinger GG, Frank-Bertoncelj M, Lakota K, Žigon P, Sodin-Semrl S, Čučnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):307-316. doi: 10.1007/s10067-018-4231-y. Epub 2018 Aug 1.

PMID:
30069799
32.

The incidence of giant cell arteritis in Slovenia.

Pucelj NP, Hočevar A, Ješe R, Rotar Ž, Hawlina M, Fakin A, Pižem J, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):285-290. doi: 10.1007/s10067-018-4236-6. Epub 2018 Jul 30.

PMID:
30062445
33.

Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.

Lakota K, Hrušovar D, Ogrič M, Mrak-Poljšak K, Čučnik S, Tomšič M, Božič B, Žigon P, Sodin-Semrl S.

Mediators Inflamm. 2018 Feb 13;2018:8237209. doi: 10.1155/2018/8237209. eCollection 2018.

34.

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.

Kuret T, Lakota K, Mali P, Čučnik S, Praprotnik S, Tomšič M, Sodin-Semrl S.

PLoS One. 2018 Apr 4;13(4):e0195346. doi: 10.1371/journal.pone.0195346. eCollection 2018.

35.
36.

Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis.

Rotar Ž, Tomšic M, Hocevar A.

Rheumatology (Oxford). 2018 May 1;57(5):934-936. doi: 10.1093/rheumatology/kex507. No abstract available.

PMID:
29394408
37.

Giant Cell Arteritis and Malignancy-More Than Just a Coincidence?

Ješe R, Rotar Ž, Tomšič M, Hočevar A.

J Clin Rheumatol. 2018 Mar;24(2):85-86. doi: 10.1097/RHU.0000000000000697. No abstract available.

PMID:
29384830
38.

Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice.

Hočevar A, Rotar Z, Krosel M, Čučnik S, Tomšič M.

Ann Rheum Dis. 2018 Dec;77(12):e90. doi: 10.1136/annrheumdis-2017-212774. Epub 2017 Dec 13. No abstract available.

PMID:
29237619
39.

A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods.

Burja B, Kuret T, Sodin-Semrl S, Lakota K, Rotar Ž, Ješe R, Mrak-Poljšak K, Žigon P, Thallinger GG, Feichtinger J, Čučnik S, Tomšič M, Praprotnik S, Hočevar A.

Autoimmun Rev. 2018 Feb;17(2):188-194. doi: 10.1016/j.autrev.2017.11.022. Epub 2017 Nov 28. Review.

PMID:
29196244
40.

Conceptual designs of conduction cooled MgB2 magnets for 1.5 and 3.0T full body MRI systems.

Baig T, Al Amin A, Deissler RJ, Sabri L, Poole C, Brown RW, Tomsic M, Doll D, Rindfleisch M, Peng X, Mendris R, Akkus O, Sumption M, Martens M.

Supercond Sci Technol. 2017 Apr;30(4). pii: 043002. doi: 10.1088/1361-6668/aa609b. Epub 2017 Mar 9.

41.

Correlation Between Mitochondrial DNA Content Measured in Myocardium and Peripheral Blood of Patients with Non-Ischemic Heart Failure.

Knez J, Lakota K, Božič N, Okrajšek R, Cauwenberghs N, Thijs L, Kneževič I, Vrtovec B, Tomšič M, Čučnik S, Sodin-Šemrl S, Kuznetsova T, Brguljan-Hitij J.

Genet Test Mol Biomarkers. 2017 Dec;21(12):736-741. doi: 10.1089/gtmb.2017.0099. Epub 2017 Oct 31.

PMID:
29087733
42.

Physicochemical data on aqueous polymeric systems of methyl cellulose and lambda- and kappa-carrageenan: SAXS, rheological, densitometry, and sound velocity measurements.

Cerar J, Dogsa I, Jamnik A, Tomšič M.

Data Brief. 2017 Sep 20;15:427-438. doi: 10.1016/j.dib.2017.09.025. eCollection 2017 Dec.

43.

The role of colour doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: A prospective study.

Ješe R, Rotar Ž, Tomšič M, Hočevar A.

Eur J Radiol. 2017 Oct;95:9-12. doi: 10.1016/j.ejrad.2017.07.007. Epub 2017 Jul 16.

PMID:
28987704
44.

The use of assistive technologies after stroke is debunking the myths about the elderly.

Tomšič M, Domajnko B, Zajc M.

Top Stroke Rehabil. 2018 Jan;25(1):28-36. doi: 10.1080/10749357.2017.1376845. Epub 2017 Sep 22.

PMID:
28934907
45.

Architecture and Transport Properties of Multifilamentary MgB2 Strands for MRI and Low AC Loss Applications.

Wan F, Sumption MD, Rindfleisch MA, Tomsic MJ, Collings EW.

IEEE Trans Appl Supercond. 2017 Jun;27(4). pii: 6200105. doi: 10.1109/TASC.2016.2632419. Epub 2016 Nov 23.

46.

Supramolecular structure of methyl cellulose and lambda- and kappa-carrageenan in water: SAXS study using the string-of-beads model.

Dogsa I, Cerar J, Jamnik A, Tomšič M.

Carbohydr Polym. 2017 Sep 15;172:184-196. doi: 10.1016/j.carbpol.2017.04.048. Epub 2017 Apr 23.

PMID:
28606524
47.

Scurvy - surprisingly not yet extinct.

Rotar Ž, Ferkolj I, Tomšič M, Hočevar A.

Vasc Med. 2017 Aug;22(4):351-352. doi: 10.1177/1358863X17713858. Epub 2017 Jun 13. No abstract available.

PMID:
28606012
48.

NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis.

Jenko B, Praprotnik S, Tomšic M, Dolžan V.

J Med Biochem. 2016 Sep;35(3):319-323. doi: 10.1515/jomb-2016-0008. Epub 2016 Jul 6.

49.

Solid cryogen: a cooling system for future MgB2 MRI magnet.

Patel D, Hossain MS, Qiu W, Jie H, Yamauchi Y, Maeda M, Tomsic M, Choi S, Kim JH.

Sci Rep. 2017 Mar 2;7:43444. doi: 10.1038/srep43444.

50.

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.

Chatzidionysiou K, Lie E, Lukina G, Hetland ML, Hauge EM, Pavelka K, Gabay C, Scherer A, Nordström D, Canhao H, Santos MJ, Tomsic M, Rotar Z, Hernández MV, Gomez-Reino J, Ancuta I, Kvien TK, van Vollenhoven R.

J Rheumatol. 2017 Feb;44(2):162-169. doi: 10.3899/jrheum.160460. Epub 2017 Jan 15.

PMID:
28089978

Supplemental Content

Loading ...
Support Center